Search Image/Table

Welcome to China Oncology,

Journals

Publication Years

Information about the GEO data and series
Databases related to bioinformatics analysis
GSE62153 GO function analysis
GSE58399 GO function and KEGG signal pathway enrichment analysis
Enrichment of KEGG signaling pathway in GSE62153 dataset
PPI network
Bioinformatics screening of Hub gene
Venn diagram of DEG and Hub gene
Survival analysis of TCGA and CGGA database
The higher expression groups were favorable than those of patients with lower expression. A: Analysis of ERMN expression in TCGA database; B: Analysis of MOG expression in TCGA database; C: Analysis of MOBP expression in TCGA database; D: Analysis of ERMN expression in CGGA database; E: Analysis of MOG Expression in CGGA database; F: Analysis of MOBP expression in CGGA database.
mRNA expression of ERMN, MOG and MOBP genes in control tissues and glioma tissues
N: Control tissues; T: Glioma tissues. A: mRNA expression of ERMN gene in control tissues and glioma tissues; B: mRNA expression of MOG gene in control tissues and glioma tissues; C: mRNA expression of MOBP gene in control tissues and glioma tissues; D: mRNA expression of ERMN gene in different WHO grades of glioma; E: mRNA expression of MOG gene in different WHO grades of glioma; F: mRNA expression of MOBP gene in different WHO grades of glioma. *: P<0.05, compared with control tissues.
Association between ERMN, MOG and MOBP genes expressions and the patient's clinicopathological characteristics in patients with glioma （n）
Expression of ARAP1-AS1 in ccRCC in the GEPIA database and its relation to survival rate and tumor stage of the patients
A: Expression level of ARAP1-AS1 in ccRCC tissues; B: Relationship between ARAP1-AS1 expression level and tumor stage; C: Relationship between the expression levels of ARAP1-AS1 and the overall survival rate; ^*: P<0.05, compared with tumor.
ARAP1-AS1 expression in ccRCC tissues and cell lines and survival analysis of the patients
A: ccRCC tissues; B: ccRCC cell lines; C: Survival analysis; ^*: P<0.05, compared with para-cancerous tissues; #: P<0.05, compared with HK2.
Relationship between expression of ARAP1-AS1 and clinicopathological features in patients with ccRCC
Effect of ARAP1-AS1 on the proliferation, migration, and invasion capacity of ccRCC cells
A: Cell proliferation; B: Cell migration; C: Cell invasion; ^*: P<0.05, compared with si-NC.
Effect of silencing of ARAP1-AS1 on the Wnt/β-catenin signaling pathway
^*: P<0.05, compared with si-NC.
Effect of ARAP1-AS1 on the proliferation, migration, and invasion capacity of ccRCC cells
A: Silencing efficiency of sh-ARAP1-AS1; B: Growth curves of the xenograft tumors; C: Tumor weights; D: Xenograft tumors; E: Immunohistochemistry; ^*: P<0.05, compared with si-NC.
The results of GIST indicators between the different risk groups
The comparison of indicators in different risk groups
The ultrasonic findings of GIST with different locations and risk grades
A: Low-risk gastric stromal tumor; B: High-risk gastric stromal tumor; C: High-risk rectal stromal tumor; D: High-risk mesostenium stromal tumor.

page
Page 1 of 56
Total 1117 records